Home
Market Capitalization of Alkem Laboratories Ltd

Alkem Laboratories Ltd
NSE: ALKEM
Market Cap
Key Highlights
- The Market Cap of Alkem Laboratories Ltd is ₹ 55067 crore as of 21 Feb 25 .
- The Latest Trading Price of Alkem Laboratories Ltd is ₹ 4605 as of 21 Feb 15:30 .
- The Dividend Payouts of Alkem Laboratories Ltd changed from ₹ 25 on Feb 17, 2023 to ₹ 37 on Feb 14, 2025 . This represents a CAGR of 6.75% over 6 years.

Alkem Laboratories Ltd
NSE: ALKEM
Share Price
Market Price of Alkem Laboratories Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 4605.65 |
20 Feb 2025 | 4727.05 |
19 Feb 2025 | 4742.7 |
18 Feb 2025 | 4725.2 |
17 Feb 2025 | 4785.15 |
14 Feb 2025 | 4653.85 |
13 Feb 2025 | 4722.3 |
12 Feb 2025 | 4708.5 |
11 Feb 2025 | 4713.85 |
10 Feb 2025 | 4800.9 |
SWOT Analysis Of Alkem Laboratories Ltd
BlinkX Score for Alkem Laboratories Ltd
Asset Value vs Market Value of Alkem Laboratories Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Alkem Laboratories Ltd
Historical P/E Ratio of Alkem Laboratories Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Alkem Laboratories Ltd
Historical Revenue of Alkem Laboratories Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Alkem Laboratories Ltd
Historical EBITDA of Alkem Laboratories Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Alkem Laboratories Ltd
Historical Net Profit of Alkem Laboratories Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Alkem Laboratories Ltd
Historical Dividend Payouts of Alkem Laboratories Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payouts of Alkem Laboratories Ltd
About Alkem Laboratories Ltd
- Headquartered in Mumbai, India, Alkem Laboratories Limited is a leading Indian pharmaceutical company with global operations.
- The company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.
- The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals, which it markets in India and international markets.
- With a portfolio of more than 800 brands in India, Alkem is ranked the fifth largest pharmaceutical company in India in terms of domestic sales.
- The company also has presence in more than 40 international markets, with the United States being its key focus market. Alkem Laboratories Ltd was incorporated as a private limited company on August 8, 1973 at Patna under the Companies Act, 1956 and subsequently became a deemed public limited company under section 43A(2) of Companies Act, 1956 on October 26, 1988.
Alkem Laboratories Ltd News Hub
Alkem Labs PAT soars 90% YoY to Rs 545 crore in Q1
Revenue from operations stood at Rs 3,031.82 crore in June 2024 quarter, registering a growth of 2.1
Read more
09 Aug 24
Alkem Laboratories consolidated net profit rises 90.13% in the June 2024 quarter
Net profit of Alkem Laboratories rose 90.13% to Rs 545.16 crore in the quarter ended June 2024 as ag
Read more
09 Aug 24
Alkem Laboratories Ltd soars 3.33%, rises for fifth straight session
Alkem Laboratories Ltd rose for a fifth straight session today. The stock is quoting at Rs 5695.7, u
Read more
08 Aug 24
Alkem Laboratories Ltd rises for third consecutive session
Alkem Laboratories Ltd gained for a third straight session today. The stock is quoting at Rs 5407.35
Read more
06 Aug 24